Internal Medicine, Hematology & Oncology · Caldwell, ID
NPI
1598956963
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3123 Medical Dr
Caldwell, ID, 83605
Phone (208) 367-3131
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
1,844 services
Medicare patients, 2024
483
Average age 73
Drug cost, 2024
$9.2M
2,919 prescriptions
Company payments, 2025
$207K
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bobby Chawla was code 99214 (office e&m - established), 472 times for 224 patients. In total Bobby Chawla billed 1,844 services in 11 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 472 | 224 | $66.22 | $31K |
| 99215 Office E&M - Established | Office | 468 | 90 | $101.29 | $47K |
| 99214 Office E&M - Established | Facility | 272 | 133 | $68.07 | $19K |
| 99215 Office E&M - Established | Facility | 215 | 54 | $101.20 | $22K |
| 99213 Office E&M - Established | Office | 143 | 110 | $43.64 | $6,240 |
| 99213 Office E&M - Established | Facility | 88 | 75 | $43.98 | $3,870 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 60 | 55 | $10.32 | $619 |
| 99205 Office E&M - New | Office | 27 | 27 | $121.19 | $3,272 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 21 | $11.07 | $255 |
| 99205 Office E&M - New | Facility | 19 | 19 | $130.01 | $2,470 |
| 99204 Office E&M - New | Office | 13 | 13 | $89.91 | $1,169 |
By year: 2022 $111K for 1,500 services; 2023 $127K for 1,611 services; 2024 $139K for 1,844 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bobby Chawla prescribed most often to Medicare patients was Prochlorperazine Maleate, with 279 prescriptions and refills. In total Bobby Chawla wrote 2,919 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 279 | 280 | 167 | $5,769 |
| Anastrozole Generic | 225 | 501 | 77 | $3,711 |
| Dexamethasone Generic | 173 | 182 | 97 | $3,240 |
| Prednisone Generic | 114 | 130 | 35 | $537 |
| Calquence Acalabrutinib Maleate | 107 | 107 | 13 | $1.5M |
| Loperamide Loperamide Hcl | 102 | 102 | 62 | $1,586 |
| Eliquis Apixaban | 101 | 146 | 30 | $81K |
| Levothyroxine Sodium Generic | 88 | 124 | 27 | $343 |
| Imbruvica Ibrutinib | 84 | 84 | 11 | $1.3M |
| Gabapentin Generic | 83 | 93 | 25 | $994 |
| Potassium Chloride Generic | 75 | 94 | 36 | $1,261 |
| Olanzapine Generic | 74 | 74 | 42 | $973 |
| Abiraterone Acetate Generic | 72 | 72 | 12 | $191K |
| Tramadol Hcl Generic | 57 | 57 | 24 | $314 |
| Acyclovir Generic | 49 | 73 | 20 | $584 |
Brand drugs: 663 claims; generic drugs: 2,256 claims; opioid claims: 151.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bobby Chawla $207K ($207K in general payments such as food, travel and fees) from 38 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $47K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 42 | $47K |
| E.R. Squibb & Sons, L.L.C. BMY | 26 | $40K |
| GlaxoSmithKline, LLC. GSK | 18 | $21K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $20K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $19K |
| Incyte Corporation INCY | 19 | $15K |
| Amgen Inc. AMGN | 17 | $13K |
| Daiichi Sankyo Inc. 4568.T | 10 | $10K |
| EMD Serono, Inc. MRK.DE | 6 | $9,318 |
| Exelixis Inc. EXEL | 12 | $4,310 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.